Table V.
Gene name(s) | Endo-genous substrate(s) | Main Physiological role | Drug substrates / inhibitors(#) | Expression at the Brain barriers | |||||
---|---|---|---|---|---|---|---|---|---|
BBB | BSCB | BCSFB | BAB | ||||||
Efflux transporters | ABCs | ABCA2 | Lipid (cholesterol) | Sphingolipid homeostasis - Cholesterol homeostasis – Transport across the BBB | – |
+ (a) |
|||
ABCA8 | Tauro-cholate and estrone sulphate | Sphingomyelin production – Lipid transport - Cholesterol homeostasis | – |
+ (a) |
+ (b) |
+ (c) |
|||
ABCB1 (MDR1) | Phospho-lipids | Xenobiotic transport across blood-brain barrier - Phospholipid translocation | Verapamil, Saquinavir, Reserpine, Nifedipine, Mifepristone, Dexamethasone, Digoxin, Trimethoprim, Progesterone, Tacrolimus, Phenobarbital, Tamoxifen, Asciminib, Octreotide, Temozolomide, Lamotrigine |
+ (a) |
+ (b) |
+ (c) |
+p (d) |
||
ABCC1 (MRP1) | GSH, leukotriene C4, estradiol glucuronide | GSH transport - Leukotriene metabolic process - Cobalamin transport | Grepafloxacin, Saquinavir, Dactinomycin, Zoledronic acid, Atorvastatin, Saxagliptin, Acemetacin, Prasterone |
+ (c) |
|||||
ABCC2 (MRP2) | glucuronideand GSH conjugates | transport across blood-brain barrier – transport of thyroid hormone, leukotriene and bil acids | Vincristine, Methotrexate, Saquinavir, Ritonavir and Indinavir |
+ (e) |
|||||
ABCC3 (MRP3) | Bilirubin di-glucuronide, Estradiol glucuronide, GSH conjugates | Canalicular bile acid transport – Leukotriene transport | Gadoxetic acid, Ezetimibe, Raloxifene, Fexofenadine, Methotrexate, Etoposide, Lamivudine, Fluorouracil |
+p (d) |
|||||
ABCC4 (MRP4) | cAMP, cGMP, Bile acids, Steroids, GSH, Prosta-glandins | Xenobiotic transport across blood-brain barrier - Cellular communication and signalling – Prostaglandin and GSH transport | GSH, Dinoprostone, Atorvastatin, Oseltamivir, Alprostadil, Cefazolin, Nateglinide, Fluorouracil, Raloxifene, Prasterone |
+ (a) |
+ (c) |
||||
ABCC8 | Regulation of insulin secretion - Potassium ion transport |
+ (a) |
|||||||
ABCG2 (BCRP) | Wide variety of physiological compounds e.g., protopor-phyrin IX, sphingosine-1-P | Xenobiotic transport across blood-brain barrier – Biotin transport – Cellular detoxification – Heme biosynthetic process | Topotecan, Glyburide, Pravastatin, Doxorubicin, Mitoxantrone, Prazosin, Etoposide, Cerivastatin, Tamoxifen, Sumatriptan, Alvocidib, Ivermectin, Oxaliplatin, Leflunomide, Mycophenolate mofetil |
+ (a) |
+ (b) |
+ (c) |
+p (d) |
||
Organic anion transporting polypeptides | OATPs |
SLCO 1A2 (OATP 1A2) |
Conjugated and unconjugated bile acids | Recycling of bile acids and salts | Pravastatin, Enalapril, Rocuronium, Budesonide, Levofloxacin, Indomethacin, Deoxycholic acid, Fexofenadine | + | |||
SLCO 2B1 (OATP 2B1) |
Prosta-glandins (PGD2, PGE1, PGE2), leukotriene C4, thrombo-xane B2 and iloprost | Recycling of bile acids and salts - Heme catabolic process | Tolbutamide, Ibuprofen, Salicylic acid, Montelukast, Simeprevir Opicapone, Pravastatin, Dinoprostone, Fexofenadine | + |
+p (d) |
||||
SLCO 3A1 (OATP 3A1) |
Estrone-3-sulfate, PGE1, PGE2, vasopressin, thyroxine | Transport across the BBB - Prostaglandin transport | Safinamide, Dinoprostone, Methotrexate, Iloprost, Conjugated estrogens, Alprostadil# |
+ (c) |
|||||
Other potential members such as SLCO1A1, SLCO1A4, SLCO1C1, SLCO1B1, SLCO1B3, SLCO1B7, SLCO2A1, SLCO4A1, SLCO4C1, SLCO5A1 & SLCO6A1 | |||||||||
Organic anion transporters | OATs |
SLC 22A6 (OAT1) |
Glutarate | Alpha-ketoglutarate transport - Renal tubular secretion | Didanosine, Famotidine, Probenecid, Lamivudine, Latanoprost, Furosemide |
+p (d) |
|||
SLC 22A8 (OAT3) |
Estrone 3-sulfate |
Excretion/ detoxification of endogenous and exogenous organic anions in brain and kidney |
Valaciclovir, Oseltamivir, Saxagliptin, Allopurinol, Avibactam, Cefdinir, Edaravone, Sitagliptin, Budesonide, Ibuprofen#, Indomethacin#, Diclofenac# |
+ (c) |
+p (d) |
||||
Organic cation transport | OCTs |
SLC 22A2 (OCT2) |
Dopamine, nor-adrenaline, serotonin, choline | Transport across the BBB - Neurotransmitter clearance | Dalfampridine, Dofetilide, Terbutaline, Histamine, Amantadine, Metformin, Memantine, Pramipexole, Reserpine, Lamivudine, Amiloride#, Amiodarone# |
+p (d) |
|||
Multidrug and toxin extrusion | MATEs |
SLC 47A1 (MATE1) |
Estrone sulfate | Secretion of cationic drugs - Transport of bile salts and organic acids |
Cefradine, Metformin, Cimetidine, Cephalexin, Acyclovir, Ganciclovir Abemaciclib, Brigatinib, Relebactam, Fosdenopterin,, Famotidine#, Verapamil# |
+ (c) |
+p (d) |
||
Amino acid transporters | EAATs | SLC1A3 (EAAT1) | L-Glu, L-Asp & D-Asp | Glutamate synaptic transmission | Glu and Asp analogues |
+ (a) |
+ (b) |
+ (c) |
|
SLC1A2 (EAAT2) |
+ (b) |
+ (b) |
|||||||
ASCTs | SLC1A4 (ASCT1) | Ala, Ser, Cys and Thr | D-Ser synaptic transmission | – | + | ||||
SLC1A5 (ASCT2) | Broad substrate specificity | Nutritional and developmental functions | Fluciclovine (18F), Serine conjugates | + (a) | |||||
NAT |
SLC 6A12 (BGT1) |
Betaine and GABA | GABAergic transmission | Guvacine# | + (a) | ||||
CATs | SLC7A1 (CAT1) | Cationic AAs (Arg, Lys and Orn) | Transport of Arg - Signalling pathways such as mTORC and activation of macrophages | – |
+ (a) |
+ (c) |
|||
HATs | SLC7A5 (LAT1) | Large neutral AAs. | Activation of mTOR signalling pathways – transport of thyroid hormones | Levodopa, Pregabalin, Baclofen, Gapepentin |
+ (a) |
||||
SLC7A11 (xCT) | Cys, Glu | Regulation of Cys and Glu metabolic processes | Sulfasalazine#, Thimerosal# |
+p (d) |
|||||
SNATs |
SLC 38A2 (SNAT2) |
Small neutral AAs (L-Ala, L-Cys, L-Ser, L-His, L-Gln and L-Met) | Transport AAs across the BBB and placental barrier – Glutamate Neurotransmitter Cycle | – | + | + | |||
SLC 38A3 (SNAT3) |
Gln, His, Asn, Ala | Regulation of Gln/Glu cycle - Nutritional and developmental functions | – | + (b) |
+ (b) |
||||
PEPT |
SLC 15A2 (PEPT2) |
Oligo-peptides & Dipeptides |
Transport across BBB – Innate immune response | Quinapril, Ubenimex, Valaciclovir, Bestatin, Cefadroxil, Amoxicillin#, Chlorpropamide# |
+p (d) |
||||
Monocarboxylate transporters | MCTs |
SLC 16A1 (MCT1) |
Lactate, pyruvate, branched chain oxo acids | Pyruvate metabolic process - glucose homeostasis – Transport across BBB | Salicylic acid, Foscarnet, Pravastatin, Probenecid#, Niflumic acid# |
+ (a) |
+ (b) |
+ (c) |
+p (d) |
SLC 16A3 (MCT4) |
α-Ketoisovalerate, Oxamic Acid, Pyruvic acid |
+ (c) |
+ | ||||||
SLC 16A4 (MCT5) |
– |
+ (c) |
|||||||
SLC 16A2 (MCT8) |
Thyroid hormone transporter | Transport across the BBB - Thyroid hormone metabolic process | Leucine, Thyroid-Porcine, Levothyroxine#, Liotrix# |
+ (b) |
+ (b) |
+ (c) |
+p (d) |
||
Glucose transporter | GLUTs | SLC2A1 (GLUT1) | Glucose, aldoses | Most important energy carrier of the brain - Promotes retinal cone survival | Fludeoxyglucose (18F), Glucosamine, Resveratrol, Ascorbic acid, Butabarbital#, Etomidate# |
+ (a) |
+ (b) |
+ (c) |
+p (d) |
Other influx transporters | SLC5A6 (SMVT) | Panto-thenate, biotin and lipoate | Vitamin transporter activity – Transport across the BBB | Gabapentin enacarbil, Biotin |
+ (b) |
+ (b) |
|||
SLC 29A1 (ENT1) |
Nucleosides (adenosine) | Nucleoside and neurotransmitter transport | Cytarabine, Fludarabine, Gemcitabine, Ribavirin, Fluorouracil, Cannabidiol#, Troglitazone# |
+ (a) |
+ (c) |
||||
SLC 29A4 (PMAT) |
Monoamine neurotransmitt-ers | Neurotransmitter transport – Transport across the BBB | Metformin, Adenosine |
+ (c) |
|||||
SLC 44A1 (CTL1) |
Choline | Membrane synthesis and myelin production – Transport across the BBB | Choline salicylate |
+ (b) |
+ (b) |
||||
SLC 44A2 (CTL2) |
+ (b) |
+ (b) |
|||||||
SLC6A8 (CRT1) | Creatine | Creatine metabolic process | – | + |
+ (c) |
||||
SLC 19A1 (RFC1) |
Reduced folates | Folate transport – Transport across the BBB | Pralatrexate, Methotrexate, Levomefolic acid, Trimetrexate |
+ (a) |
|||||
SLC 27A1 (FATP1) |
long-chain fatty acids (LCFA) | Transport of fatty acids – Cell signaling – Transport across the BBB | – | + |
BBB, Blood-brain barrier; BSCB, Blood spinal cord barrier; BCSFB, Blood-cerebrospinal fluid barrier; BAB, Blood-arachnoid Barrier; AAs, Amino acids; GSH, Glutathione; L-Glu, L-Glutamate; L-Asp, L-Aspartate; D-Asp, D-Aspartate; Ala, Alanine; Ser, Serine; Cys, Cysteine; Thr, Threonine; Arg, Arginine; Lys, Lysine; Orn, Ornithine; L-His, L-Histidine; L-Gln, L-Glutamine; L-Met, L-Methionine; Asn, Asparagine; p, pig
#refers to inhibitors; (a) data obtained from the reference (9); (b) data obtained from the reference (5); (c) data obtained from the reference (66); (d) data obtained from the reference (36); (e) data obtained from the reference (46)